Cite
HARVARD Citation
Dawson, J. et al. (2022). Pathway profiling of a novel SRC inhibitor, AZD0424, in combination with MEK inhibitors for cancer treatment. Molecular oncology. 16 (5), pp. 1072-1090. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Dawson, J. et al. (2022). Pathway profiling of a novel SRC inhibitor, AZD0424, in combination with MEK inhibitors for cancer treatment. Molecular oncology. 16 (5), pp. 1072-1090. [Online].